文献速递生殖医学

多囊卵巢综合征中的胰岛素抵抗:正常血糖-高胰岛素钳夹研究的系统综述与荟萃分析

Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies.
PubMed 文献 · Hum Reprod · 2016-10-07

该系统综述与荟萃分析检索截至2015年5月30日的Medline和All EBM数据库,纳入28篇文章,比较绝经前多囊卵巢综合征(PCOS)女性与对照组的胰岛素敏感性(采用正常血糖-高胰岛素钳夹测定)。结果显示PCOS患者胰岛素敏感性平均降低27%(99%CI ±6%),且不依赖BMI;BMI较高使PCOS患者胰岛素敏感性进一步降低15%(99%CI ±8%)。

要点

  • PCOS患者胰岛素敏感性较对照组平均降低27%(99%CI ±6%),且不依赖BMI。
  • BMI较高使PCOS患者胰岛素敏感性额外降低15%(99%CI ±8%)。
  • 低性激素结合球蛋白(SHBG)水平与胰岛素敏感性降低10%(99%CI ±10%)相关,且不受BMI混杂。

核心结论

  • PCOS患者存在固有的胰岛素敏感性降低(-27%),该降低不依赖BMI。

研究设计与样本

  • 系统综述与荟萃分析,检索Medline和All EBM数据库截至2015年5月30日发表的研究,纳入比较绝经前PCOS女性与对照组胰岛素敏感性的研究,胰岛素敏感性采用正常血糖-高胰岛素钳夹测定;共检索到4881篇文章,最终28篇纳入荟萃分析。

主要发现

  • PCOS女性整体胰岛素敏感性较对照组降低(平均效应-27%,99%CI ±6%;幅度大,最可能降低)。
  • 与对照组相比,PCOS女性中较高的BMI使胰岛素敏感性降低进一步加剧(-15%,99%CI ±8%;幅度中等,最可能降低)。
  • 仅按原始美国国立卫生研究院(NIH)标准诊断与按Rotterdam标准诊断的PCOS女性之间,胰岛素敏感性无明确差异。
  • 低水平性激素结合球蛋白(SHBG)与胰岛素敏感性降低相关(-10%,99%CI ±10%;幅度小,很可能为负相关),且不受BMI混杂。

局限性

  • 本系统综述与荟萃分析继承了小样本量、数据缺失(如部分激素、腰围和臀围)以及缺乏Rotterdam标准表型报告等混杂问题,限制了证据合成与荟萃分析。
  • 睾酮经BMI校正后与胰岛素敏感性显示出意外的相互作用,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the degree of intrinsic insulin resistance (IR) in women with polycystic ovary syndrome (PCOS) and the relative contribution of BMI to overall IR based on meta-analysis of gold standard insulin clamp studies? SUMMARY ANSWER: We report an inherent reduction (-27%) of insulin sensitivity (IS) in PCOS patients, which was independent of BMI. WHAT IS ALREADY KNOWN: PCOS is prevalent, complex and underpinned by IR but controversies surround the degree of intrinsic IR in PCOS, the effect of BMI and the impact of the different diagnostic criteria (NIH versus Rotterdam) in PCOS. STUDY DESIGN, SIZE, DURATION: A systematic review and meta-analysis of Medline and All EBM databases was undertaken of studies published up to 30 May 2015. Studies were included if premenopausal women diagnosed with PCOS were compared with a control group for IS, measured by the gold standard euglycaemic-hyperinsulinaemic clamp. The systematic review adheres to the principles of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Meta-analyses were performed using mixed modelling and magnitude-based inferences expressed as mean effect ±99% CI. We inferred the effect was small, moderate or large relative to a smallest important change of -3.7% or 3.8% derived by standardisation. Effects were deemed unclear when the CI overlapped smallest important positive and negative values. Effects were qualified with probabilities reflecting uncertainty in the magnitude of the true value (likely, 75-95%; very likely, 95-99.5%; most likely, >99.5%). PARTICIPANTS/MATERIALS, SETTING, METHOD: A total of 4881 articles were returned from the search. Of these, 28 articles were included in the meta-analysis. MAIN RESULTS AND THE ROLE OF CHANCE: Overall IS was lower in women with PCOS compared with controls (mean effect -27%, 99% CI ±6%; large, most likely lower). A higher BMI exacerbated the reduction in IS by -15% (±8%; moderate, most likely lower) in PCOS compared with control women. There was no clear difference in IS between women diagnosed by the original National Institutes of Health (NIH) criteria alone compared with those diagnosed by the Rotterdam criteria. Low levels of sex hormone-binding globulin (SHBG) were associated with reduced levels of IS (-10%, ±10%; small, very likely negative), which was not confounded by BMI. LIMITATIONS, REASONS FOR CAUTION: This systematic review and meta-analysis inherited the confounding problems of small sample sizes, missing data (e.g. some hormones, waist and hip girths) and the lack of Rotterdam criteria phenotype reporting, limiting the evidence synthesis and meta-analysis. WIDER IMPLICATIONS OF THE FINDINGS: BMI has a greater impact on IS in PCOS than in controls. SHBG appears a potentially valuable marker of IR in PCOS, whereas testosterone after adjustment for BMI demonstrated an unexpected interplay with IS which warrants further investigation. STUDY FUNDING/COMPETING INTERESTS: This work was supported by grants from the National Health & Medical Research Council (NHMRC), grant number 606553 (H.J.T., N.K.S.), as well as Monash University. H.J.T. is an NHMRC Research Fellow. N.K.S. is supported through the Australian Government's Collaborative Research Networks (CRN) programme. The funding bodies played no role in the design, methods, data management or analysis or in the decision to publish. All authors declare no conflict of interests. REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Cassar S, Misso ML, Hopkins WG, et al. Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies. Hum Reprod. 2016. PMID: 27907900

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。